Illumina
ILMNHealthcare · Diagnostics & Research · US282.86USD+5.57%
StratDeckIllumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Price · Past year
Loading chart…
Checks
- Pass: Price trending up The figures
- Pass: Sales growing in line with its peers The figures
- Pass: More profitable than similar companies The figures
- Pass: Analysts rate it a buy The figures
- Fail: Costs more than similar companies The figures
- Pass: Beat profit forecasts The figures
Share
Keep researching
Where next from ILMN
Other stocks you may like
Fundamentals
SEC EDGAR
Yahoo FinanceShowHide
What's happening?
ILMN is beating Healthcare this month The figures
- 1D
- +5.57%
- 7D
- +4.08%
- 1M
- +18.44%
- 3M
- +48.20%
- 6M
- +116.75%
- YTD
- +115.66%
What is the market expecting?
StratDeckCosts more than similar companies, and analysts expect the price to fall The figures
Value score vs Healthcare peers
5- Fwd P/E46.21
- P/B15.18
- P/E52.810
- Rev growth+9.4%66
Not scored on Yield. The rest were reweighted to make up the difference.
Is the business delivering?
Sales are growing in line with similar companies, and profit per share is down The figures
Earnings by quarter
Latest quarter 207M · +73.0M on the quarter before · -28.0M on a year earlier
- 705MNov24+2.69B
- 186MFeb25-519M
- 131MMay25-55.0M
- 235MJul25+104M
- 150MOct25-85.0M
- 334MFeb26+184M
- 134MApr26-200M
- 207MJul26+73.0M
How does it compare?
Nearest in Healthcare on valueStratDeckILMN is worse value than most Healthcare stocks The figures
What happens next?
Reports next on 29 Oct, in 7 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.